Skip to main content

Temis Acquires i3 Analytics

NEW YORK (GenomeWeb News) – Temis, a semantic solutions provider, has acquired i3 Analytics, a developer of data analytics and visualization technologies for the life sciences, for an undisclosed amount.

According to Temis, the acquisition adds a complementary solution to its existing product portfolio and brings in additional technical know-how to the company that should help expand its life sciences footprint.

I3 Analytics markets Biopharma Navigator, a software-as-a-service platform that provides users with tools to explore and visualize the biopharmaceutical landscape. It gives users access to information that helps them make informed clinical, regulatory, and business decisions.

Temis intends to integrate Biopharma Navigator into Luxid, its flagship platform for identifying and extracting information used to semantically enrich customers' content, and make it available for a variety of applications.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.